183 related articles for article (PubMed ID: 24627286)
21. Rapid progression after ibrutinib discontinuation in a patient with mantle cell lymphoma who has severe coronavirus disease 2019 infection.
Hindilerden F; Yönal Hindilerden İ; Diz Küçükkaya R
Balkan Med J; 2021 Mar; 38(2):141-142. PubMed ID: 33045824
[No Abstract] [Full Text] [Related]
22. Minimal change disease associated with newly diagnosed mantle cell lymphoma.
Khow KS; Yong AS; Yong TY; Kuss BJ; Barbara JA; Li JY
Ren Fail; 2014 May; 36(4):634-7. PubMed ID: 24502759
[TBL] [Abstract][Full Text] [Related]
23. Blastic mantle cell lymphoma developing concurrently in a patient with chronic myelogenous leukemia and a review of the literature.
Rodler E; Welborn J; Hatcher S; Unger K; Larkin E; Gumerlock PH; Wun T; Richman C
Am J Hematol; 2004 Apr; 75(4):231-8. PubMed ID: 15054816
[TBL] [Abstract][Full Text] [Related]
24. Primary gastric mantle cell lymphoma in a patient with long standing history of Crohn's disease.
Raderer M; Püspök A; Birkner T; Streubel B; Chott A
Leuk Lymphoma; 2004 Jul; 45(7):1459-62. PubMed ID: 15359648
[TBL] [Abstract][Full Text] [Related]
25. Mantle cell lymphoma of the gastrointestinal tract presenting with multiple intussusceptions--case report and review of literature.
Kella VK; Constantine R; Parikh NS; Reed M; Cosgrove JM; Abo SM; King S
World J Surg Oncol; 2009 Jul; 7():60. PubMed ID: 19646237
[TBL] [Abstract][Full Text] [Related]
26. Leukemic Non-nodal Mantle Cell Lymphoma: Diagnosis and Treatment.
Jain AG; Chang CC; Ahmad S; Mori S
Curr Treat Options Oncol; 2019 Nov; 20(12):85. PubMed ID: 31776787
[TBL] [Abstract][Full Text] [Related]
27. Pathologic splenic rupture as the presentation of mantle cell lymphoma.
Strickland AH; Marsden KA; McArdle J; Lowenthal RM
Leuk Lymphoma; 2001 Mar; 41(1-2):197-201. PubMed ID: 11342374
[TBL] [Abstract][Full Text] [Related]
28. Presentation of mantle cell lymphoma with symptoms of prostatism.
Atay MH; Kelkitli E; Alici O; Cilingir F; Turgut M
Pol Arch Med Wewn; 2013; 123(11):643-4. PubMed ID: 24296665
[No Abstract] [Full Text] [Related]
29. Spontaneous rupture of the spleen as the presenting feature of the blastoid variant of mantle cell lymphoma.
Mason KD; Juneja SK
Clin Lab Haematol; 2003 Aug; 25(4):263-5. PubMed ID: 12890168
[TBL] [Abstract][Full Text] [Related]
30. Composite lymphoma comprising mantle cell lymphoma and Epstein-Barr virus positive classic Hodgkin lymphoma: A rare case.
Sharma S; Singh V; Bisaria D; Tangri R
Indian J Pathol Microbiol; 2019; 62(3):488-490. PubMed ID: 31361250
[No Abstract] [Full Text] [Related]
31. Multiple lymphomatous polyposis as a sole presentation of mantle cell lymphoma.
Mar N; Khaled S; Kencana F; Gergis U; Khattak F; Brodsky N; Gotlieb V
J Clin Gastroenterol; 2006 Aug; 40(7):653-4. PubMed ID: 16917415
[No Abstract] [Full Text] [Related]
32. Leukemic non-nodal mantle cell lymphomas have a distinct phenotype and are associated with deletion of PARP1 and 13q14.
Gallo M; Cacheux V; Vincent L; Bret C; Tempier A; Guittard C; Macé A; Leventoux N; Costes V; Szablewski V
Virchows Arch; 2016 Dec; 469(6):697-706. PubMed ID: 27605053
[TBL] [Abstract][Full Text] [Related]
33. Spontaneous splenic rupture in mantle cell lymphoma with leukemic variant.
Raza S; Doll DC
Blood; 2014 Jul; 124(3):316. PubMed ID: 25162078
[No Abstract] [Full Text] [Related]
34. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
Rasmussen PK
Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
[TBL] [Abstract][Full Text] [Related]
35. Lacrimal gland and extensive subcutaneous tissue involvement by mantle cell lymphoma.
Khodarahmi I; Ghesani N
Blood; 2017 Aug; 130(9):1174. PubMed ID: 28860327
[No Abstract] [Full Text] [Related]
36. Lenalidomide for aggressive B-cell lymphoma involving the central nervous system?
Cox MC; Mannino G; Lionetto L; Naso V; Simmaco M; Spiriti MA
Am J Hematol; 2011 Nov; 86(11):957. PubMed ID: 21990093
[No Abstract] [Full Text] [Related]
37. Unusual sites of involvement in non-Hodgkin's lymphoma: Case 3. Intussusception as a rare complication of mantle-cell lymphoma.
Sucker C; Klima KM; Doelken G; Heidecke CD; Lorenz G; Stockschlaeder M
J Clin Oncol; 2002 Nov; 20(21):4397-8. PubMed ID: 12409341
[No Abstract] [Full Text] [Related]
38. Successful intraperitoneal rituximab treatment in a patient with therapy-resistant malignant ascites due to mantle cell lymphoma.
Mörth C; Hagberg H
Ann Hematol; 2015 Oct; 94(10):1757-8. PubMed ID: 26155910
[No Abstract] [Full Text] [Related]
39. CD23 expression in mantle cell lymphoma is associated with CD200 expression, leukemic non-nodal form, and a better prognosis.
Saksena A; Yin CC; Xu J; Li J; Zhou J; Wang SA; Lin P; Tang G; Wang L; Wang M; Miranda RN; Medeiros LJ; Li S
Hum Pathol; 2019 Jul; 89():71-80. PubMed ID: 31054894
[TBL] [Abstract][Full Text] [Related]
40. Mantle cell lymphoma first presenting as immune complex-mediated glomerulonephritis: a case report.
Abeysekera RA; Wazil AW; Nanayakkara N; Ratnatunga N; Fernando KM; Thinnarachchi J
J Med Case Rep; 2015 May; 9():115. PubMed ID: 25986232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
